Multidisciplinary Reviews in Malignant Hematology - low grade B cell Non Hodgkin Lymphomas (2026)

Friday, October 23, 2026, 7:30 AM - 1:50 PM, Westin Book Cadillac, Detroit, MI


AMA PRA Category 1 Credits™ (5.00 hours), AMA PRA Non-Physician Attendance (5.00 hours)

The field of low-grade B-cell Non-Hodgkin Lymphomas, its diagnosis, and multidisciplinary management is a constantly evolving field. Over the recent past we have witnessed how an enhanced classification system has helped us better assess disease biology/function for improved therapeutic intervention, while a deeper understanding of the underlying disease mechanisms has in turn informed us of the ways in which we can devise management strategies using traditional, targeted, immunomodulatory, and cellular therapies. This update is intended to enhance our understanding of the mechanisms behind the development and progression of low-grade B-cell Non-Hodgkin Lymphomas, the ways in which they are now being treated, their resistance pathways, and the ever-increasing novel management concepts being tested in the lab and clinic. The hope is that we can come away from this conference with a better understanding of these disorders and use this knowledge to both further the field and better help in the care of our patients.

1. Understand the morphologic and cytogenetic evaluation of low-grade B-cell Non-Hodgkin Lymphomas.
2. Evaluate multi-modality management of newly diagnosed and relapsed low-grade B-cell Non-Hodgkin Lymphomas.
3. Assess the sequencing of T-cell directed therapy in low-grade B-cell Non-Hodgkin Lymphomas.
4. Conceptualize how newer treatment modalities might modify standards of care in the near future.

If you are an employee of a pharmaceutical or device company, please see the exhibitor tab before registering.

Henry Ford Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement: Henry Ford Health designates this Live Activity for a maximum of 5.00 AMA PRA Category 1 Credit™(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accessibility Statement

The Henry Ford Health Office of Continuing Medical Education is committed to ensuring that its programs, services, goods, and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act and the ADA Amendments Act of 2008. If you have needs that require special accommodations, please contact [email protected]. 

Cancellation Policy

The Henry Ford Health Office of Continuing Medical Education reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties. Please send cancellation requests to [email protected]. 

Mitigation of Relevant Financial Relationships

Henry Ford Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Henry Ford Health has implemented mechanisms to identify and mitigate financial relationships with ineligible companies for all individuals in a position to control content of this activity. All relevant financial relationships have been mitigated prior to the commencement of this activity.

Friday, October 23, 2026

If your company is interested in supporting this event, please complete this form

If you are an employee of a pharmaceutical or device company and are interested in attending this event, your attendance must be organized by emailing [email protected]. Types of industry employees include PhDs, MSLs, pharmacologists, clinical research associates, sales reps, etc. Do not register on this webpage; your registration will be refunded.

If you have further inquiries, please email [email protected] and [email protected].